Scientists are testing a nasal spray COVID-19 vaccine they say has been very effective in lab trials and may someday be a viable option for patients.
Scientists are testing a nasal spray they say has been very effective in lab trials and may someday be a viable option for patients in need of a COVID-19 shot.There's been a lot of confusion over COVID-19 shots and boosters regarding how many you need and when you need them.
From allergy relief to protection from the flu, a quick pump delivers medication directly into the respiratory system. Now, Yale researchers are testing the promising booster nasal spray. Iwasaki said current mRNA boosters lose strength over time and are not as effective in the nose and respiratory tract. The Yale nasal spray contains spike proteins from the coronavirus.
For some patients who are reluctant to get the COVID booster because they hate needles, a nasal spray could be a better option. Iwasaki said there are also other benefits.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
China estimates 250 million people caught COVID-19 since end of 'zero-COVID' policy: reportChina abruptly ended its 'zero-COVID' policies following nationwide protests, but the lack of proper vaccination levels and hospital preparedness left the country vulnerable.
Consulte Mais informação »
UCLA Scientists Say FDA-Approved Eye-Disease Drug May Also Help Fight COVIDAn interdisciplinary research team led by the University of California, Los Angeles (UCLA) discovered that a drug already approved by the Food and Drug Administration (FDA) for eye disease, verteporfin, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. Their laboratory study ide
Consulte Mais informação »
New law ends COVID-19 vaccine mandate for US troopsThe contentious political issue, which has divided America, forced more than 8,400 troops out of the military for refusing to obey a lawful order when they declined to get the vaccine.
Consulte Mais informação »
Omicron subvariant XBB jumps to 18% of U.S. COVID cases, CDC saysThe highly-contagious Omicron subvariant XBB has surged to more than 50% of COVID-19 cases in the northeastern United States and risks spreading fast as millions of Americans begin holiday travel on Friday.
Consulte Mais informação »